J B Demoulin - JoVE Visualize

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Oncogene|October 13, 2015

PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinibF A Arts, D Chand, C Pecquet, et al.

Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|April 26, 2011

[Role of PDGF and FGF receptors in cancer]J B Demoulin, Sandrine Medves, Federica Toffalini, et al.

Molecular and Cellular Biology|September 1, 1996

A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9J B Demoulin, C Uyttenhove, E Van Roost, et al.

Pathologie-Biologie|August 15, 2006

JAK2, the JAK2 V617F mutant and cytokine receptorsJ Staerk, A Kallin, Y Royer, et al.

FEBS Letters|October 12, 2000

Role of insulin receptor substrate-2 in interleukin-9-dependent proliferationJ B Demoulin, L Grasso, J M Atkins, et al.

Oncogene|June 12, 2013

PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutationsA I Velghe, S Van Cauwenberghe, A A Polyansky, et al.

Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Oncogene|October 13, 2015

PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinibF A Arts, D Chand, C Pecquet, et al.

Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|April 26, 2011

[Role of PDGF and FGF receptors in cancer]J B Demoulin, Sandrine Medves, Federica Toffalini, et al.

Molecular and Cellular Biology|September 1, 1996

A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9J B Demoulin, C Uyttenhove, E Van Roost, et al.

Pathologie-Biologie|August 15, 2006

JAK2, the JAK2 V617F mutant and cytokine receptorsJ Staerk, A Kallin, Y Royer, et al.

FEBS Letters|October 12, 2000

Role of insulin receptor substrate-2 in interleukin-9-dependent proliferationJ B Demoulin, L Grasso, J M Atkins, et al.

Oncogene|June 12, 2013

PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutationsA I Velghe, S Van Cauwenberghe, A A Polyansky, et al.

Pageof 2